Randomised trial of text messaging on adherence to cardiovascular preventive treatment ( INTERACT trial ) . 
<br>
<br> BACKGROUND <font color="blue">About_1</font> <font color="blue">one_1</font> <font color="blue">third_1</font> <font color="blue">of_1</font> <font color="blue">patients_4</font> <font color="blue">prescribed_4</font> <font color="blue">blood_4</font> <font color="blue">pressure_4</font> <font color="blue">or_3</font> <font color="blue">lipid_3</font> <font color="blue">-_3</font> <font color="blue">lowering_3</font> <font color="blue">drugs_3</font> <font color="blue">for_3</font> <font color="blue">the_3</font> <font color="blue">prevention_3</font> <font color="blue">of_3</font> <font color="blue">coronary_4</font> <font color="blue">heart_4</font> <font color="blue">disease_4</font> <font color="blue">and_4</font> <font color="blue">stroke_4</font> do not take their medication as prescribed . We conducted a randomized trial to evaluate text messaging as a means of improving adherence to cardiovascular disease preventive treatment . 
<br> METHODS <font color="blue">303_7</font> <font color="blue">patients_7</font> <font color="blue">taking_7</font> <font color="blue">blood_7</font> <font color="blue">pressure_7</font> <font color="blue">and/or_6</font> <font color="blue">lipid_6</font> <font color="blue">-_6</font> <font color="blue">lowering_6</font> <font color="blue">medications_6</font> <font color="blue">were_2</font> <font color="blue">randomly_2</font> <font color="blue">assigned_2</font> to being sent text messages ( Text group , 151 ) or not being sent them ( No text group , 152 ) . Texts were sent daily for 2 weeks , alternate days for 2 weeks and weekly thereafter for 22 weeks ( 6 months overall ) , using an automated computer programme . <font color="blue">Patients_1</font> <font color="blue">were_1</font> <font color="blue">asked_1</font> <font color="blue">to_1</font> <font color="blue">respond_1</font> on whether they had taken their medication , whether the text reminded them to do so if they had forgotten , and if they had not taken their medication to determine if there was a reason for not doing so . At 6 months , use of medication was assessed . 
<br> RESULTS Two patients were lost to follow - up , providing data on 301 for analysis . In the <font color="blue">No_1</font> <font color="blue">text_1</font> <font color="blue">group_1</font> <font color="blue">38/151_1</font> <font color="blue">(_1</font> <font color="blue">25%_1</font> <font color="blue">)_1</font> took less than 80% of the prescribed regimen ( ie . stopped medication completely or took it on fewer than 22 of the last 28 days of follow - up ) <font color="blue">compared_1</font> <font color="blue">to_1</font> <font color="blue">14/150_1</font> <font color="blue">patients_1</font> <font color="blue">(_1</font> <font color="blue">9%_1</font> <font color="blue">)_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">Text_1</font> <font color="blue">group_1</font> - an improvement in adherence affecting 16 per 100 patients ( 95% CI 7 to 24 ) , p<0.001 . The texts reminded 98/151 patients ( 65% ) to take medication on at least one occasion and lead to 20/151 ( 13% ) who stopped taking medication because of concern over efficacy or side - effects , resuming treatment . 
<br> CONCLUSIONS <font color="blue">In_1</font> <font color="blue">patients_4</font> <font color="blue">taking_4</font> <font color="blue">blood_4</font> <font color="blue">pressure_4</font> <font color="blue">or_4</font> <font color="blue">lipid_4</font> <font color="blue">-_4</font> <font color="blue">lowering_4</font> <font color="blue">treatment_4</font> <font color="blue">for_3</font> <font color="blue">the_3</font> <font color="blue">prevention_3</font> <font color="blue">of_3</font> <font color="blue">cardiovascular_4</font> <font color="blue">disease_4</font> <font color="blue">,_4</font> text messaging improved medication adherence compared with no text messaging . 
<br> TRIAL REGISTRATION Controlled - Trials.com ISRCTN74757601 .